Correlation between pentosidine and endothelin-1 in subjects undergoing chronic hemodialysis

Hormone and Metabolic Research

Volumn 38, Issue 12, 2006, Pages 817-820

  Odetti, Patrizio ^a   Monacelli, F ^a   Storace, D ^a   Robaudo, C ^a   Rossi, S ^a   Deferrari, G ^a   Barreca, T ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Endothelin 1; Glycation; Hemodialysis; Pentosidine

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ENDOTHELIN 1; PENTOSIDINE;

ADULT; ARTICLE; BLOOD CHEMISTRY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ARGININE; CASE-CONTROL STUDIES; ENDOTHELIN-1; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LYSINE; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 33846019278     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-956501     Document Type: Article

References (30)

1. Wautier JL, Schmidt AM. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 2004; 95: 233-238
2. Vlassara H, Palace MR. Glycoxidation: the menace of diabetes and aging. Mt Sinai J Med 2003; 70: 232-241
3. Takahashi M, Oikawa M, Nagano A. Effect of age and menopause on serum concentrations of pentosidine, an advanced glycation end product. J Gerontol A Biol Sci Med Sci 2000; 55: M137-M140
4. Lapolla A, Reitano R, Baccarin L, Sartore G, Plebani M, Fedele D. Pentosidine plasma levels and relation with metabolic control in diabetic patients. Horm Metab Res 2005; 37: 252-256
5. Bohlender JM, Franke S, Stein G, Wolf G. Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 2005; 289: F645-F659
6. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int 1999; 55: 389-399
7. Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005; 67: 3-21
8. Miyauchi T, Masaki T. Pathophysioiogy of endothelin in the cardiovascular system. Annu Rev Physiol 1999; 61: 391-415
9. Sorokin A, Kohan DE. Physiology and pathology of endothelin-1 in renal mesangium. Am J Physiol Renal Physiol 2003; 285: F579-F589
10. Demuth K, Blacher J, Guerin AP, Benoit MO, Moatti N, Safar ME, London GM. Endothelin and cardiovascular remodelling in end-stage renal disease. Nephrol Dial Transplant 1998; 13: 375-383
11. Rosendorff C. Endothelin, vascular hypertrophy, and hypertension. Cardiovasc Drugs Ther 1996; 10: 795-802
12. Wolf SC, Amend T, Risler T, Amann K, Brehm BR. Influence of endothelin receptor antagonists on myocardial protein kinase C isoforms in uraemic cardiomyopathy. Clin Sci (Lond) 2002; 103 (Suppl 48): 276S-279S
13. Gagliardi GM, Rossi S, Manes MT, Gerace G, Martire V, Caruso F, Vocaturo G, De Napoli N. Impact of left ventricular patterns and diastolic dysfunction on hemodialysis patients. G Ital Nefrol 2004; 21: 45-50
14. Quehenberger P, Bierhaus A, Fasching P, Muellner C, Klevesath M, Hong M, Stier G, Sattler M, Schleicher E, Speiser W, Nawroth PP. Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes 2000; 49: 1561-1570
15. Odetti P, Cosso L, Pronzato MA, Dapino D, Gurreri G. Plasma advanced glycosylation end-products in maintenance haemodialysis patients. Nephrol Dial Transplant 1995; 10: 2110-2113
16. Odetti P, Fogarty J, Sell DR, Monnier VM. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 1992; 41: 153-159
17. Bierhaus A, Chevion S, Chevion M, Hofmann M, Quehenberger P, Illmer T et al. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 1997; 46: 1481-1490
18. Michael JR, Markewitz BA, Kohan DE. Oxidant stress regulates basal endothelin-1 production by cultured rat pulmonary endothelial cells. Am J Physiol 1997; 273: L768-774
19. Yura T, Fukunaga M, Khan R, Nassar GN, Badr KF, Montero A. Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells. Kidney Int 1999; 56: 471-478
20. Kahler J, Ewert A, Weckmuller J, Stobbe S, Mittman C, Koster R et al. Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells. J Cardiovasc Pharmacol 2001; 38: 49-57
21. Weiss MF, Scivittaro V, Anderson JM. Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis 2001; 37: 970-980
22. Kahler J, Mendel S, Weckmuller J, Orzechowski HD, Mittmann C, Koster R et al. Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter. J Mol Cell Cardiol 2000; 32: 1429-1437
23. Ruef J, Moser M, Kubler W, Bode C. Induction of endothelin-1 expression by oxidative stress in vascular smooth muscle cells. Cardiovasc Pathol 2001; 10: 311-315
24. Sonin NV, Garcia-Pagan JC, Nakanishi K, Zhang JX, Clemens MG. Patterns of vasoregulatory gene expression in the liver response to ischemia/reperfusion and endotoxemia. Shock 1999; 11: 175-179
25. Ishizuka T, Takamizawa-Matsumoto M, Suzuki K, Kurita A. Endothelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor alpha-stimulated vascular endothelial cells. Eur J Pharmacol 1999; 369: 237-245
26. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 1995; 96: 1395-1403
27. Chakravarthy U, Hayes RG, Stitt AW, McAuley E, Archer DB. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes 1998; 47: 945-952
28. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 1997; 272: 17810-17814
29. Huttunen HJ, Fages C, Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999; 274: 19919-19924
30. Barton M, Kiowski W. The therapeutic potential of endothelin receptor antagonists in cardiovascular disease. Curr Hypertens Rep 2001; 3: 322-330